As part of the educational programme planned to replace the Masterclass included in the MPE Annual General Meeting (AGM) 2020, which was cancelled due to the outbreak of the coronavirus infection, MPE is organising a Webinars series.
The first webinar on myeloma and AL amyloidosis treatment updates will be held this Wednesday 11 March from 18.30 to 19.30 CET. The talk will be given by Dr Inger Nijhof, Department of Hematology, VU University Medical Center, Amsterdam, Netherlands who will give a 40-minute presentation on the latest developments in the treatment and care of myeloma and AL amyloidosis patients. The session will be followed by a 20-minute Q&A session.
Registration is free of charge. Feel free to forward the registration link to colleagues and other patient advocates who might be interested in attending the webinar.
Should you be unable to attend the webinar, please feel free to send your questions in advance to and we will make sure they reach our speaker.
Check below the list of webinars and register now:
Topic
Speaker
Date and time
Link to register
Webinar on myeloma and AL amyloidosis treatment updates
Dr Inger Nijhof, Department of Hematology, VU University Medical Center, Amsterdam, Netherlands
Wednesday 11 March (18:30 – 19.30 CET)
Webinar on reimbursement and Health Technology Assessment (HTA)
Neil Bertelsen, Steering Committee member at Health Technology Assessment International (HTAi)
Wednesday 18 March (18:00 – 19:00 CET)
Webinar on big data in haematology, the Harmony example
Ana Rodríguez, Institute of Cancer Molecular and Biology (USAL-CSIC), Salamanca, Spain
Thursday 2 April
(18:00 – 19:00 CET)
Webinar on Minimal Residual Disease (MRD) in myeloma and related diseases
Paula van Hennik, Committee for Medicinal Products for Human Use (CHMP) member at the European Medicine Agency (EMA)
Monday 20 April
(18:00 – 19:00 CET)
Webinar on personalised medicines in myeloma and AL amyloidosis
Dr Francesca Bonello, Università degli Studi di Torino
Monday 6 May
(18:00 – 19:00 CET)
Webinar on how to develop patient materials
Alice Baron, Information Manager at Myeloma UK (MUK)